MDXG MiMedx Group Inc.

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

MARIETTA, Ga., Feb. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 45th Annual Health Care Conference.

TD Cowen's 45th Annual Health Care Conference is taking place on March 3-5, 2025, at the Boston Marriott Copley Place in Boston, MA. The conference incorporates presentations, fireside chats and innovative panel discussions, moderated by members of the TD Cowen research team, that focus on various aspects of the Health Care industry.

TD Cowen | Boston, MA | March 3-5, 2025

Presentation: Tuesday, March 4, 2025 at 11:10 AM ET

Webcast:

Institutional investors interested in meeting with senior management may contact their TD Cowen representative.

A live webcast of the presentation will be available on the Events page of the Investors section of the Company’s website or through the conference site by using the link above. A replay will be available on the Company’s website following the event.

About MIMEDX

MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit .

Contact:

Matt Notarianni

Investor Relations

470-304-7291



EN
27/02/2025

Underlying

MDXGMiMedx Group Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MiMedx Group Inc.

 PRESS RELEASE
Free
MDXG MiMedx Group I...

MIMEDX Announces Publication in the Journal of Inflammation Focused on...

MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro Study investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair MARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM...

17h / 10m 1 EN
 PRESS RELEASE
Free
MDXG MiMedx Group I...

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When Compared to Standard of Care (“SOC”) Publication Adds to Large Compendium of Evidence for MIMEDX’s Leading Product Portfolio Trial Enrollment Ongoing MARIETTA, Ga., Nov. 13, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the publication of interim results from its CAMPAIGN trial, a randomized controlled trial (“RCT”) designed to...

November 13, 2025 1 EN
 PRESS RELEASE
Free
MDXG MiMedx Group I...

MIMEDX to Participate in Upcoming Investor Conferences

MIMEDX to Participate in Upcoming Investor Conferences MARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum 16th Annual Alpha Select Conference | New York, NYTuesday, November 18, 20251:1 sessions Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NYThursday, November 20, 20251:1 sessions Investors interested in meeting with senior management at these events may contact their resp...

November 10, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 42.69
AVY Avery Dennison ...
SLB.N SCHLUMBERGER NV ... (+32)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

AVY AVERY DENNISON CORPORATION
SLB.N SCHLUMBERGER NV
ZEUS OLYMPIC STEEL INC.
SEE SEALED AIR CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
OMCL OMNICELL INC.
MDXG MIMEDX GROUP INC.
LOCO EL POLLO LOCO HOLDINGS INC
HVT HAVERTY FURNITURE COS. INC.
GMED GLOBUS MEDICAL INC CLASS A
FFIC FLUSHING FINANCIAL CORP.
EXPO EXPONENT INC.
CRK COMSTOCK RESOURCES INC.
BJRI BJ'S RESTAURANTS INC.
CTS CTS CORP.
HLX HELIX ENERGY SOLUTIONS GROUP INC.
PTEN PATTERSON-UTI ENERGY INC.
NOVT NOVANTA INC
WGO WINNEBAGO INDUSTRIES INC.
WHD CACTUS INC
NRIX NURIX THERAPEUTICS
VTRS VIATRIS INC.
APA APA CORPORATION
REYN REYNOLDS CONSUMER PRODUCTS
DIBS 1STDIBS COM INC
ZI ZOOMINFO TECHNOLOGIES INC
CTO CTO REALTY GROWTH INC
JANX JANUX THERAPEUTICS INC
MCW MISTER CAR WASH INC
AFRI FORAFRIC GLOBAL PLC
FTREV FORTREA HOLDINGS INC.
INO INOVIO PHARMACEUTICALS INC.
11/05/25 November 5, 2025 1 EN
 PRESS RELEASE
Free
MDXG MiMedx Group I...

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule Company is Well Positioned to Continue to Compete and Grow MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”) final rule, which was published on Friday. “Over the last several years, we have actively engaged with numerous stakeholders to advocate for much-needed reform of the Medicare reimbursement system for skin substitutes. CMS i...

November 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch